News

10. Oktober 2016

NOXXON PHARMA DEMONSTRATES SYNERGIES BETWEEN NOX-A12 AND

THERAPIES WORKING THROUGH T CELLS OR NK CELLS

Preclinical data presented at the European Society for Medical Oncology (ESMO) conference

shows synergy of NOXXON’s lead compound NOX-A12...

28. September 2016

OXID eSales räumt in vier Kategorien den begehrten Shop Usability Award 2016 ab

22. September 2016

An Geschäftsideen mangelt es Gründern nicht, nur fehlt oft das Kapital. Investoren können das ändern.

Ein Artikel von Dominik Bath  - Volksstimme, 22.09.2016

13. September 2016

Combination therapy with Glutaminyl Cyclase (QC) inhibitor PQ912 & pGlu-Abeta specific antibody PBD-C06 shows clear additive effects in reducing pGlu-Abeta as well as Abeta in Alzheimer-mouse model

7. September 2016

Promising new findings for Probiodrug's Glutaminyl Cyclase - inhibitor in an inflammation animal model

In an acute peritonitis model PQ912 inhibits monocyte infiltration, increases eosinophils and enhances resolvin D2, an important lipid mediator which...

30. August 2016

Probiodrug reports financial results for H1 2016

26. August 2016

"Gründen und Wachsen in Mitteldeutschland 2016"

Lesen Sie in der Sonderausgabe den Artikel von Herrn Dr. Jan Alberti zu unserer IBG-Beteiligung an der UniNow GmbH Seite 22

 

25. August 2016

 

Probiodrug to present at US Life Sciences Conferences

Attendance at key conferences in September 2016

23. August 2016

Probiodrug AG to Publish First Half 2016 Results on 30 August 2016

16. August 2016

Probiodrug to present at European Life Sciences Conferences

Attendance at key conferences during August and September 2016

Seiten